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ickle cell anemia (SCA) is a severe disease characterized by
 recessive autosomal inheritance. However, despite being
 monogenic disease, SCA has clinical heterogeneity as
ifferent individuals with the same genotype have different
linical aspects.1 Thus, the clinical diversity of SCA has been
ttributed to socioeconomic and environmental factors, and
lso to genetic modulators, which have been widely inves-
igated in order to explain the heterogeneous pattern of the
isease.1 Regarding the classic genetic modulators associated
ith SCA, we  can mention the beta ()-globin gene cluster
aplotypes, alpha-thalassemia (-Thal), as well as epistatic
enetic variations related to quantitative trait loci (QTLS) of
everal genes which act singly or interacting with each other,
or instance the presence of a gene polymorphism in BCL11A
nd the olfactory receptor gene and its association with fetal
emoglobin (Hb F) concentration.2–4 Genome-wide studies
mphasize multigene interactions and the clinical proﬁle of
CA patients.5,6 -globin gene cluster haplotypes have been
escribed and named according to the geographic region
here they were ﬁrst identiﬁed, and have also been correlated
o differential Hb F levels,7,8 with some haplotypes (Bantu
nd Benin) associated with lower Hb F levels and less disease
everity.9,10 Several studies related to -globin gene cluster
aplotypes have been performed and show differential dis-
ribution related to the studied group as these markers have
een used as an anthropological tool, as well as their role
n modulating laboratorial and clinical characteristics of SCA
atients.9–16
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eserved.-Thal is characterized by a deﬁciency or absence
of -globin chain synthesis and its combination with 
chain variants decreases the concentration of abnormal
hemoglobin.17–19 The reduced synthesis of the alpha globin
chain results in changes in hematological parameters,
decreasing the degree of hemolysis and cellular dehydration,
and increasing the ratio between the volume and the cell
membrane area of red blood cells in sickle cell patients.17,20
The coexistence of -Thal with SCA has been associated to
greater survival, and also with a reduction in the occurrence
of chronic ulcers in the malleolar region. However, with the
reduction of hemolysis and increase of hematocrit, there is an
increase of blood viscosity; this is a risk for vaso-occlusion, and
consequently, an increase in the frequency of painful crises
and other clinical complications, such as retinopathies and
bone necrosis.21 Kato et al., in a review of reports related to
sickle cell disease phenotypes, proposed that patients with
the -Thal trait have less hemolysis and endothelial alter-
ations, but present a sub-phenotype associated to increases
in blood viscosity and vaso-occlusion.22 Therefore, the coex-
istence of -globin gene cluster haplotypes and -Thal has
shown changes in the severity of the clinical proﬁle of sickle
cell disease patients (Table 1).
Despite several studies describing the presence of these
markers and their possible inﬂuences on the phenotype of), Centro de Pesquisas Gonc¸alo Moniz, Laboratório Hematologia
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SCA patients, changes described in a speciﬁc population are
not necessarily found in others; this consolidates the concept
that although the genetic event is unique and related to one
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Table 1 – Description of studies related to the coexistence of -globin gene haplotypes and -Thal and possible changes
in the severity of clinical proﬁle of sickle cell disease (SCD).
Description of study Possible changes Author
Association of -globin haplotype and
chronic inﬂammatory proﬁle in sickle
cell anemia (SCA)
-Globin  haplotype is associated with inﬂammatory proﬁle Bandeira et al.23
Inﬂuence of the (S) haplotype and
-thalassemia on stroke development
in SCA.
Result  suggest that only the (S) haplotypes and the 
(3.7 kb)-thalassemia genotype modulate the prevalence of
stroke in the studied SCA population
Domingos et al.24
Study of pediatric severity score in SCD
patients
Alpha-gene deletions were not associated with a lower
pediatric severity score, but patients were clearly
differentiated by their -globin genotype
Joly  et al.25
Genetic polymorphisms and
cerebrovascular disease (CVD) in
children with SCA
Children  with Bantu/Atypical (S)-globin gene haplotype had
15 times more chance of CVD and there was no difference in
CVD among -Thal carriers
Filho  et al.26
Association of -globin gene haplotypes
and -Thal as a risk factor of
glomerulopathy in SCA
Results  suggest a strong protective effect of -Thal against
glomerulopathy in adult SCA patients
Nebor  et al.27
Inﬂuence of -globin gene haplotype,
co-inherited -Thal trait and Hb F on
steady-state serum bilirubin levels in
SCA
The -globin haplotype and co-existing -Thal trait did not
have any signiﬁcant inﬂuence on serum bilirubin levels
Adekile et al.28
The -globin gene cluster haplotypes in
SCA
-Globin gene haplotypes showed differences related only to
Hb F levels and blood transfusion therapy, presence of -Thal
was associated to hematological alteration and spleen
sequestration events
Adorno  et al.29
Molecular characteristics of pediatric
patients with SCA and stroke
Neonates with four or more alpha-genes, whose -haplotype is
Ben/CAR, atypical, or CAR/CAR seem to be at a higher risk for
stroke
Sarnaik et al.30
Effect of microdeletions in the alpha
globin gene and sickle cell
glomerulopathy
Coinheritance of microdeletions in the alpha-globin gene locus
in SCA patients confers “renoprotection”
Guasch  et al.31
Genotype-phenotype correlation of SCD
in the United Arab Emirates
African haplotypes (Bantu and Benin) are related to a severe
clinical presentation, and coinheritance of -Thal trait in the
African haplotypes had an ameliorating effect on hemolytic
episodes, but vaso-occlusive crises were more frequent
el-Kalla et al.32
Effect of -Thal on SCA linked to the
Arab-Indian haplotype in India
-Thal is a powerful and additional epistatic factor on the
Indian subcontinent
Mukherjee  et al.33
(S) haplotype and alpha-globin gene
patterns among SCA patients in Kuwait
SCA patients with coexistent alpha-Thal trait did not have
severe recurrent infections and none had gallstones. The high
frequencies of the Saudi Arabia/India (S) haplotype and
-Thal trait contribute to the mild nature of the disease among
Kuwaiti Arabs
Adekile  et al.34
Inﬂuence of -Thal trait on spleen
function in SCA patients with high Hb F
-Thal trait appears to be associated with normal splenic
function in SCA patients
Adekile  et al.35
Effect of -Thal and -globin gene cluster
haplotypes on the hematological and
clinical features of SCA in Brazil
The CAR haplotype may be associated with more severe
disease
Figueiredo et al.36
(S) haplotypes, alpha-globin gene status,
and hematological data of SCD patients
in Guadeloupe
-Haplotypes and alpha-gene status have been correlated with
hematological parameters in these patients
Keclard et al.37
Gender and haplotype effects upon
hematological manifestations of adult
SCA
Alpha thalassemia reduced the MCV, increased hemoglobin
concentration, and lowered reticulocyte counts, regardless of
haplotype. Hb F levels were not affected by the presence of
-Thal, and gender and -globin gene cluster haplotype
interact signiﬁcantly in the modulation of Hb F and anemia in
adults with hemoglobin SS
Steinberg  et al.38
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Table 1 (Continued)
Description of study Possible changes Author
-Globin gene cluster haplotype and
-Thal do not correlate with the acute
clinical manifestations of SCD in
children
Absence of association of -globin gene cluster haplotype and
-Thal in acute clinical pattern of SCD patients
de  Montalembert et al.39
The Senegal DNA haplotype is associated
with the amelioration of anemia in
The  Senegal -like globin gene cluster haplotype is associated
with an amelioration of the hemolytic anemia that





























2African-American SCA patients characterizes SCD
oint mutation in the  globin gene (HBB), the clinical pattern
f the disease involves multiple organs and systems, which
ffects the activation of a complex network of mechanisms
nd pathways not clearly understood. In this context, there is
 high diversity of ﬁndings which are not yet globally consol-
dated about a common prognostic marker involving the SCA
roﬁle, except the genetic origin of the disease, the presence
f hemoglobin S.
In this issue of the Revista Brasileira de Hematologia e Hemoter-
pia, Camilo-Araújo present an analysis of the frequency of
S-globin haplotypes and alpha-thalassemia, and their inﬂu-
nce on clinical manifestations and the hematological proﬁle
f children with sickle cell anemia.41
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